255 related articles for article (PubMed ID: 21080112)
1. Treatment of chronic migraine.
Diener HC; Holle D; Dodick D
Curr Pain Headache Rep; 2011 Feb; 15(1):64-9. PubMed ID: 21080112
[TBL] [Abstract][Full Text] [Related]
2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
3. [Chronic and Refractory Migraine: How to Diagnose and Treat].
Parreira E; Luzeiro I; Pereira Monteiro JM
Acta Med Port; 2020 Nov; 33(11):753-760. PubMed ID: 33160424
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
[TBL] [Abstract][Full Text] [Related]
6. [Chronic migraine].
Diener HC; Holle D; Müller D; Nägel S; Rabe K
Nervenarzt; 2013 Dec; 84(12):1460-6. PubMed ID: 24337617
[TBL] [Abstract][Full Text] [Related]
7. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
Dodick DW; Turkel CC; DeGryse RE; Diener HC; Lipton RB; Aurora SK; Nolan ME; Silberstein SD
J Pain; 2015 Feb; 16(2):164-75. PubMed ID: 25464159
[TBL] [Abstract][Full Text] [Related]
8. Topiramate in migraine progression.
Ruiz L; Ferrandi D
J Headache Pain; 2009 Dec; 10(6):419-22. PubMed ID: 19838625
[TBL] [Abstract][Full Text] [Related]
9. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
[TBL] [Abstract][Full Text] [Related]
10. Chronic migraine: a therapeutic challenge for clinicians.
Irimia P; Carmona-Abellán M; Martínez-Vila E
Expert Opin Emerg Drugs; 2012 Dec; 17(4):445-7. PubMed ID: 22998764
[TBL] [Abstract][Full Text] [Related]
11. [Chronic migraine: treatment].
Pascual J
Rev Neurol; 2012 Apr; 54 Suppl 2():S31-8. PubMed ID: 22532241
[TBL] [Abstract][Full Text] [Related]
12. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.
Diener HC; Dodick DW; Goadsby PJ; Bigal ME; Bussone G; Silberstein SD; Mathew N; Ascher S; Morein J; Hulihan JF; Biondi DM; Greenberg SJ
Cephalalgia; 2009 Oct; 29(10):1021-7. PubMed ID: 19735529
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
Mathew NT; Kailasam J; Meadors L
Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
Silberstein S; Diener HC; Lipton R; Goadsby P; Dodick D; Bussone G; Freitag F; Schwalen S; Ascher S; Morein J; Greenberg S; Biondi D; Hulihan J
Headache; 2008 Jul; 48(7):1087-95. PubMed ID: 18687081
[TBL] [Abstract][Full Text] [Related]
15. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
Mathew NT; Jaffri SF
Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of topiramate in migraine prevention.
Ferrari A; Tiraferri I; Neri L; Sternieri E
Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1169-81. PubMed ID: 21756204
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and mechanism of anticonvulsant drugs in migraine.
Hoffmann J; Akerman S; Goadsby PJ
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):191-201. PubMed ID: 24494792
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
20. Update on the Pharmacological Treatment of Chronic Migraine.
Sun-Edelstein C; Rapoport AM
Curr Pain Headache Rep; 2016 Jan; 20(1):6. PubMed ID: 26728188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
